Correction: Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis

Ya-Ling Hsu; Jen-Yu Hung; Yen-Lung Lee; Feng-Wei Chen; Kuo-Feng Chang; Wei-An Chang; Ying-Ming Tsai; Inn-Wen Chong; Po-Lin Kuo

doi:10.18632/oncotarget.26609

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis

PDF | How to cite

Oncotarget. 2019; 10:616-616. https://doi.org/10.18632/oncotarget.26609

Metrics: PDF 1537 views | ?

Ya-Ling Hsu^1,*, Jen-Yu Hung^2,3,*, Yen-Lung Lee⁴, Feng-Wei Chen⁵, Kuo-Feng Chang⁶, Wei-An Chang^3,5, Ying-Ming Tsai^1,3, Inn-Wen Chong^3,7 and Po-Lin Kuo^5,8,9

¹ Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
² School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
³ Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
⁴ Division of Thoracic surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
⁵ Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
⁶ Welgene Biotech. Inc, Taipei, Taiwan
⁷ Department of Respiratory Therapy, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
⁸ Center for Biomarkers and Biotech Drugs, Kaohsiung Medical University, Kaohsiung, Taiwan
⁹ Institute of Medical Science and Technology, National Sun Yat-Sen University, Kaohsiung, Taiwan
^* These authors have contributed equally to this work

Published: January 15, 2019

This article has been corrected: The correct Acknowledgments and Funding information is given below:

ACKNOWLEDGMENTS AND FUNDING

This study was supported by grants from the Ministry of Science and Technology (MOST 106-2314-B-037-064; MOST 104-2320-B-037-014-MY3; MOST 104-2314-B-037-053-MY4; MOST 103-2320-B-037-006-MY3), the Kaohsiung Medical University “Aim for the Top 500 Universities Grant” (Grant No. KMU-TP105C05), the Kaohsiung Medical University “Aim for the Top Journals Grant” (Grant No. KMU-DT106005), and the Kaohsiung Medical University Hospital Research Foundation (KMUH106-6R13).

Original article: Oncotarget. 2017; 8:104831-104854. DOI: https://doi.org/10.18632/oncotarget.21022.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26609

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis